Exelixis Stock News & Updates

[WKN: 936718 | Symbol: EXEL]

Biotech Stocks: AI Will Trigger Innovation-Driven Growth - Here are Three Stocks at 52-Week Highs That Traders Can Now Pick Up!

With BB Biotech (Traderfox model portfolio) and Medpace (US model portfolio), we are already invested...

Breakout Opportunity in the Biotechnology Sector - Exelixis is the Market Leader in Kidney Cancer with a P/E Ratio of 14.5

The biotech heavyweight Biogen reported better-than-expected numbers today. The stock is up more than...

AI Triggers an Innovation-Driven Growth Phase in the Biotech Sector. Two Leading Stocks Aae Moving Onto the Watchlist for our US Portfolio!

We have successfully invested in AI infrastructure stocks. Now, we see biotechnology as a future beneficiary...

Exelixis: Zanzalintinib as a Major Hope in Cancer Therapies Ahead of FDA Approval

Business Model: Exelixis focuses on targeted cancer therapies with kinase inhibitors. The main product,...

Exelixis: Zanzalintinib as a Great Hope in Cancer Therapies Before FDA Approval

Business model: Exelixis focuses on targeted cancer therapies with kinase inhibitors. The main product...

Exelixis - Oncology Specialist With Strong Pipeline, Positive Phase III Clinical Study Data for Zanzalintinib Opens Billion-Dollar Revenue Potential!

Business drivers: The US company Exelixis (EXEL) specializes in the development of active ingredients...

Stocks in Action USA: Exelixis, Fiserv, Rezolve AI

Exelixis (EXEL) achieves breakthrough in colorectal cancer research with new drug combination! The...

Accumulation: Acadia Healthcare, ProSiebenSat.1, Exelixis, Nextracker and Advanced Drainage Systems.

Acadia Healthcare - Clinic operator benefits from rising patient numbers! Business driver: Acadia...

Stocks in Action USA: Oklo, Super Micro Computer and Exelixis.

Oklo (OKLO) - the energy start-up makes progress in building its first mini-nuclear power plant – site...